ENTHEON BIOMEDICAL

A new dimension in addiction treatment

Entheon is in a unique position to challenge the narrative and expectations around addiction recovery.

Intersecting established pharmacology with emerging medical technology, Entheon is developing a data-driven and comprehensive addiction recovery solution that personalizes patient care through all stages of treatment.

Despite the options available today, instances of addiction and related deaths continue to rise. Combining the clinical and nonclinical research of DMT with genetics and EEG biomarkers into a comprehensive treatment system will enable us to leverage empirical, objective evidence that is currently missing from available addiction treatments

Latest News Release

Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Glad to announce that our Observational Study, EBIQ-101 is progressing as planned with first-patient dose having recently taken place.

Read Now
PAST RELEASES
See all releases